Retrovir: Foundational Antiretroviral Therapy for HIV Management - Evidence-Based Review

Product Description Retrovir is the brand name for the antiretroviral medication zidovudine (AZT), a nucleoside reverse transcriptase inhibitor (NRTI). It was the first drug approved by the FDA for the treatment of HIV infection, marking a pivotal turn in the management of what was then a universally fatal disease. While its role has evolved with the development of newer agents and combination therapies, Retrovir remains a foundational component in certain HIV treatment and prevention strategies, including the prevention of mother-to-child transmission.